207 related articles for article (PubMed ID: 37424088)
1. Breakthrough pain and rapid-onset opioids in patients with cancer pain: a narrative review.
Yeo J
J Yeungnam Med Sci; 2024 Jan; 41(1):22-29. PubMed ID: 37424088
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation.
Takigawa C; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
Jpn J Clin Oncol; 2015 Jan; 45(1):67-74. PubMed ID: 25381384
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of rapid-onset opioids for breakthrough pain.
Smith H
CNS Drugs; 2012 Jun; 26(6):509-35. PubMed ID: 22668247
[TBL] [Abstract][Full Text] [Related]
4. Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice.
Bossi P; Escobar Y; Pea F
Front Pain Res (Lausanne); 2022; 3():893530. PubMed ID: 35721659
[TBL] [Abstract][Full Text] [Related]
5. Impact and management of breakthrough pain in cancer.
Zeppetella G
Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
[TBL] [Abstract][Full Text] [Related]
6. Opioids for the management of breakthrough pain in cancer patients.
Zeppetella G; Davies AN
Cochrane Database Syst Rev; 2013 Oct; (10):CD004311. PubMed ID: 24142465
[TBL] [Abstract][Full Text] [Related]
7. Recent development in therapeutics for breakthrough pain.
Davis MP
Expert Rev Neurother; 2010 May; 10(5):757-73. PubMed ID: 20420495
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough pain-novel analgesics.
Randive S; Mehta V
Curr Clin Pharmacol; 2012 May; 7(2):116-20. PubMed ID: 22432841
[TBL] [Abstract][Full Text] [Related]
9. Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients.
Mercadante S
Expert Opin Pharmacother; 2012 Apr; 13(6):873-8. PubMed ID: 22424558
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
[TBL] [Abstract][Full Text] [Related]
11. Considerations in selecting rapid-onset opioids for the management of breakthrough pain.
Smith HS
J Pain Res; 2013; 6():189-200. PubMed ID: 23503653
[TBL] [Abstract][Full Text] [Related]
12. The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing.
Mercadante S
Crit Rev Oncol Hematol; 2011 Dec; 80(3):460-5. PubMed ID: 21215653
[TBL] [Abstract][Full Text] [Related]
13. Bibliometric Network Analysis on Rapid-Onset Opioids for Breakthrough Cancer Pain Treatment.
Cascella M; Monaco F; Nocerino D; Chinè E; Carpenedo R; Picerno P; Migliaccio L; Armignacco A; Franceschini G; Coluccia S; Gennaro PD; Tracey MC; Forte CA; Tafuri M; Crispo A; Cutugno F; Vittori A; Natoli S; Cuomo A
J Pain Symptom Manage; 2022 Jun; 63(6):1041-1050. PubMed ID: 35151801
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
[No Abstract] [Full Text] [Related]
15. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse.
Manchikanti L; Singh V; Caraway DL; Benyamin RM
Pain Physician; 2011; 14(2):E103-17. PubMed ID: 21412376
[TBL] [Abstract][Full Text] [Related]
16. Opioids for the management of breakthrough (episodic) pain in cancer patients.
Zeppetella G; Ribeiro MD
Cochrane Database Syst Rev; 2006 Jan; (1):CD004311. PubMed ID: 16437482
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough pain: the importance of baseline analgesic regimen with opioids.
Zampi M; Morabito A; Salvato F; Vinciguerra A
Transl Med UniSa; 2012 May; 3():62-6. PubMed ID: 23905054
[TBL] [Abstract][Full Text] [Related]
18. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl sublingual spray for breakthrough pain in cancer patients.
Zeppetella G
Pain Ther; 2013 Jun; 2(1):1-9. PubMed ID: 25135032
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
